SCHEMBL3062385

SCHEMBL3062385

[O-][n+]1cccc(O)c1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11455637 0.75
SCHEMBL4989309 0.75
SCHEMBL3319954 0.75
SCHEMBL100824 0.72 MAPT (0.43)
SCHEMBL34468885 0.72 MAPT (0.43)
SCHEMBL8847256 0.70 ALDH1A1 (0.46)
SCHEMBL31746076 0.70 MAPT (0.42)
SCHEMBL5944671 0.70 MAPT (0.34)
SCHEMBL4437293 0.70 MAPT (0.42)
SCHEMBL31746077 0.70 MAPT (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4454748-A1 SWITCHABLE ADSORPTION MATERIALS BASED ON PUNICINES AND YLIDES FOR SELECTIVE SEPARATION AND RECYCLING OF METAL CATIONS AND METAL-CONTAINING ANIONS FROM COMPLEX SOLUTIONS Technische Universität Clausthal (DE) 2024-10-30 EP disclosed
EP-3847889-A1 BIOCIDAL COMPOSITIONS COMPRISING IRON CHELATORS Arch Chemicals, Inc. (US) 2021-07-14 EP disclosed
US-20200170249-A1 Biocidal Compositions Comprising Iron Chelators ARCH CHEMICALS, INC. 2020-06-04 US disclosed
US-10433548-B2 Biocidal compositions comprising iron chelators ARCH CHEMICALS, INC. (US) 2019-10-08 US disclosed
US-9156772-B2 Fluoride-releasing compositions NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-10-13 US disclosed
EP-2906038-A1 BIOCIDAL COMPOSITIONS COMPRISING IRON CHELATORS Arch Chemicals, Inc. (US) 2015-08-19 EP disclosed
US-20140154189-A1 Biocidal Compositions Comprising Iron Chelators ARCH CHEMICALS, INC. (US) 2014-06-05 US disclosed
US-20140088308-A1 Fluoride-Releasing Compositions BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2014-03-27 US disclosed
US-8598381-B2 Fluoride-releasing compositions BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2013-12-03 US disclosed
US-20120264939-A1 Fluoride-Releasing Compositions NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-10-18 US disclosed
US-8217173-B2 Fluoride-releasing compositions BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2012-07-10 US disclosed
US-20100279986-A1 HETEROCYCLIC DERIVED METALLOPROTEASE INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2010-11-04 US disclosed
US-20100261902-A1 Fluoride-Releasing Compositions BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY (US) 2010-10-14 US disclosed
US-7803793-B2 Heterocyclic derived metalloprotease inhibitors JANSSEN PHARMACEUTICA NV (BE) 2010-09-28 US disclosed
EP-2089365-A1 HETEROCYCLIC DERIVED METALLOPROTEASE INHIBITORS Janssen Pharmaceutica, N.V. (BE) 2009-08-19 EP disclosed
WO-2008100907-A2 FLUORIDE-RELEASING COMPOSITIONS BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND ARGRICULTURAL AND MECHANICAL COLLEGE (US) 2008-08-21 WO disclosed
US-20080103129-A1 HETEROCYCLIC DERIVED METALLOPROTEASE INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2008-05-01 US disclosed
WO-2008045668-A1 HETEROCYCLIC DERIVED METALLOPROTEASE INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2008-04-17 WO disclosed